Clonixin Nitroso Impurity
Specifications
Product name
Clonixin Nitroso Impurity
SRC CAT No
SRC-N014476
CAS No
NA
Mol.F.
C13H10ClN3O3
Mol.Wt.
291.7
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
2-((3-Chloro-2-methylphenyl)(nitroso)amino)nicotinic acid
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Clonixin is an NSAID used to relieve pain associated with arthritis, migraines, and various soft tissue disorders. Clonixin is a non-steroidal anti-inflammatory drug.Clonixin Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Clonixin Nitroso CAS NO:NA chemically represented as 2-((3-Chloro-2-methylphenyl)(nitroso)amino)nicotinic acid . Synchemia is the leading manufacturing and exporter of Clonixin Nitroso . We supply Clonixin Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Share your requirement and our team will take it forward with
clarity, confidentiality, and technical precision.
Related Products
N-Nitroso Lacosamide EP Impurity I
| CAT No | SRC-N0143044 |
| CAS No | NA |
| Mol.F. | C19H22N4O4 |
| Mol.Wt. | 370.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lacosamide EP Impurity K
| CAT No | SRC-N0143045 |
| CAS No | NA |
| Mol.F. | C12H13N3O3 |
| Mol.Wt. | 247.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lacosamide N-Methyl Impurity
| CAT No | SRC-N0143046 |
| CAS No | NA |
| Mol.F. | C14H19N3O4 |
| Mol.Wt. | 293.32g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso N-Methyl lacosamide
| CAT No | SRC-N0143047 |
| CAS No | NA |
| Mol.F. | C14H19N3O4 |
| Mol.Wt. | 293.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalone
| CAT No | SRC-N0143048 |
| CAS No | NA |
| Mol.F. | C19H21N3O4 |
| Mol.Wt. | 355.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol Cyclohexyl Analog
| CAT No | SRC-N0143049 |
| CAS No | NA |
| Mol.F. | C19H29N3O4 |
| Mol.Wt. | 363.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol Dibenzyl Analogue
| CAT No | SRC-N0143050 |
| CAS No | NA |
| Mol.F. | C24H23N3O4 |
| Mol.Wt. | 417.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol EP Impurity A
| CAT No | SRC-N0143051 |
| CAS No | NA |
| Mol.F. | C19H22N2O5 |
| Mol.Wt. | 358.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol EP Impurity B
| CAT No | SRC-N0143052 |
| CAS No | NA |
| Mol.F. | C20H24N2O5 |
| Mol.Wt. | 372.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol EP Impurity C
| CAT No | SRC-N0143053 |
| CAS No | NA |
| Mol.F. | C16H17N3O4 |
| Mol.Wt. | 315.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol EP Impurity F
| CAT No | SRC-N0143054 |
| CAS No | NA |
| Mol.F. | C19H21N3O4 |
| Mol.Wt. | 355.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Labetalol EP Impurity G
| CAT No | SRC-N0143055 |
| CAS No | NA |
| Mol.F. | C19H22BrN3O4 |
| Mol.Wt. | 436.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lisinopril Impurity 1
| CAT No | SRC-N0143056 |
| CAS No | NA |
| Mol.F. | C24H34N4O8 |
| Mol.Wt. | 506.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lisinopril Impurity 3
| CAT No | SRC-N0143057 |
| CAS No | NA |
| Mol.F. | C37H52N6O9 |
| Mol.Wt. | 724.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lisinopril Impurity 6
| CAT No | SRC-N0143058 |
| CAS No | NA |
| Mol.F. | C8H12F3N3O4 |
| Mol.Wt. | 271.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Lisinopril Impurity 7
| CAT No | SRC-N0143059 |
| CAS No | NA |
| Mol.F. | C20H26F3N3O6 |
| Mol.Wt. | 461.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |